Safety, tolerability and pharmacokinetics of an NMDA receptor subunit 2B-selective negative allosteric modulator, BI 1569912: Results of three partially randomised, placebo-controlled phase I trials
- DOI
- 10.1177/02698811261481073
- Published
- 2026-09-02
- Container
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/02698811261481073,
title = {Safety, tolerability and pharmacokinetics of an NMDA receptor subunit 2B-selective negative allosteric modulator, BI 1569912: Results of three partially randomised, placebo-controlled phase I trials},
author = {Andreas Hünnemeyer and Yoichiro Ogama and Franco De Crescenzo and Rainer-Georg Goeldner and Akiko Harada and Tetsuya Katakabe and Andreas Scholz and Yury Shatillo and Sigurd D. Süssmuth and Christian Keicher},
year = {2026},
journal = {Journal of Psychopharmacology},
doi = {10.1177/02698811261481073},
url = {https://doi.org/10.1177/02698811261481073}
}RIS
TY - JOUR TI - Safety, tolerability and pharmacokinetics of an NMDA receptor subunit 2B-selective negative allosteric modulator, BI 1569912: Results of three partially randomised, placebo-controlled phase I trials AU - Andreas Hünnemeyer AU - Yoichiro Ogama AU - Franco De Crescenzo AU - Rainer-Georg Goeldner AU - Akiko Harada AU - Tetsuya Katakabe AU - Andreas Scholz AU - Yury Shatillo AU - Sigurd D. Süssmuth AU - Christian Keicher PY - 2026 JO - Journal of Psychopharmacology DO - 10.1177/02698811261481073 UR - https://doi.org/10.1177/02698811261481073 ER -
APA
Hünnemeyer, A., Ogama, Y., Crescenzo, F. D., Goeldner, R., Harada, A., Katakabe, T., Scholz, A., Shatillo, Y., Süssmuth, S. D., & Keicher, C. (2026). Safety, tolerability and pharmacokinetics of an NMDA receptor subunit 2B-selective negative allosteric modulator, BI 1569912: Results of three partially randomised, placebo-controlled phase I trials. Journal of Psychopharmacology. https://doi.org/10.1177/02698811261481073
Source records
- crossref · retrieved 2026-11-09T18:35:21.290Z